載入...
Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
PURPOSE: To conduct a Phase I trial of recombinant immunotoxin SS1P given by continuous infusion in chemoresistant solid tumors expressing mesothelin. EXPERIMENTAL DESIGN: Eligible patients had mesothelioma, ovarian, or pancreatic cancer which was recurrent or unresectable despite standard therapy,...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2009
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2754261/ https://ncbi.nlm.nih.gov/pubmed/19671873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-0062 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|